Dal Bo, M.; Gambirasi, M.; Vruzhaj, I.; Cecchin, E.; Pishdadian, A.; Toffoli, G.; Safa, A.
Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine. Int. J. Mol. Sci. 2025, 26, 4982.
https://doi.org/10.3390/ijms26114982
AMA Style
Dal Bo M, Gambirasi M, Vruzhaj I, Cecchin E, Pishdadian A, Toffoli G, Safa A.
Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine. International Journal of Molecular Sciences. 2025; 26(11):4982.
https://doi.org/10.3390/ijms26114982
Chicago/Turabian Style
Dal Bo, Michele, Marta Gambirasi, Idris Vruzhaj, Erika Cecchin, Abbas Pishdadian, Giuseppe Toffoli, and Amin Safa.
2025. "Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine" International Journal of Molecular Sciences 26, no. 11: 4982.
https://doi.org/10.3390/ijms26114982
APA Style
Dal Bo, M., Gambirasi, M., Vruzhaj, I., Cecchin, E., Pishdadian, A., Toffoli, G., & Safa, A.
(2025). Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine. International Journal of Molecular Sciences, 26(11), 4982.
https://doi.org/10.3390/ijms26114982